06.01.2023
Three new studies support the effectiveness of the JYNNEOS vaccine against mpox:
- CDC: Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023
- CDC: Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection — New York, 2022
- New England Journal of Medicine: Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States
The CDC recommends persons at high risk for mpox exposure be vaccinated with the recommended 2-dose JYNNEOS series. READ MORE
As there has recently been an uptick of new mpox cases in Chicago, providers are asked to encourage vaccination among high-risk patients in advance of the summer festival and pride parade season. Vaccination continues to be one of the most important preventive measures. Read CDC Health Alert and CDC Risk Assessment.
Provider Resources: